No Data
GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.
GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.
Shanghai Haoyuan Pharmaceutical Co., Ltd. 2024 Annual Results Express Announcement
Shanghai Haoyuan Chemexpress Makes Adjustments to Cash Management Strategy
Haoyuan Pharmaceutical (688131.SH) plans to launch a restricted stock incentive plan for 3 million shares.
Haoyuan Pharmaceutical (688131.SH) announced the draft of the restricted stock incentive plan for 2025. This time, the company is...
Express News | Shanghai Haoyuan Chemexpress Says Key Shareholders Plan to Unload up to 4.51% Stake in Three Months
Market Participants Recognise Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) Earnings Pushing Shares 27% Higher
Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) P/E Is Still On The Mark Following 31% Share Price Bounce
